Ubs Group Ag Astrazeneca PLC Call Options Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $106,896 - $129,328	1,600 Added 11.94%	15,000 $1.17 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $640,815 - $730,484	-10,500 Reduced 43.93%	13,400 $907,000
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $1.62 Million - $1.82 Million	-26,200 Reduced 52.3%	23,900 $1.61 Million
Q3 2023 Nov 09, 2023	BUY	$64.85 - $71.7 $2.04 Million - $2.26 Million	31,500 Added 169.35%	50,100 $3.39 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $328,577 - $356,307	4,700 Added 33.81%	18,600 $1.33 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $877,785 - $995,239	13,900 New	13,900 $964,000
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $6.97 Million - $8.4 Million	-125,100 Reduced 49.12%	129,600 $8.6 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $11.6 Million - $13.7 Million	214,700 Added 536.75%	254,700 $14.8 Million
Q4 2020 Feb 11, 2021	BUY	$48.52 - $58.02 $688,984 - $823,884	14,200 Added 55.04%	40,000 $2 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $4.98 Million - $5.92 Million	-117,400 Reduced 81.98%	25,800 $1.29 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $3.87 Million - $4.33 Million	103,800 Added 263.45%	143,200 $5.91 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $376,194 - $456,012	-10,600 Reduced 21.2%	39,400 $1.59 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $863,749 - $926,249	25,000 Added 100.0%	50,000 $1.76 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $820,953 - $912,087	24,900 Added 24900.0%	25,000 $874,000
Q3 2017 Nov 14, 2017	SELL	$28.96 - $34.0 $19.5 Million - $22.9 Million	-674,900 Reduced 99.99%	100 $3,000
Q2 2017 Aug 14, 2017	BUY	N/A	675,000	675,000 $23 Million

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

Price T Rowe Associates Inc Baltimore, MD

64.9M
Shares

$4.88 Billion
0.61% of portfolio
Primecap Management CO Pasadena, CA

42.6M
Shares

$3.2 Billion
2.44% of portfolio
Wellington Management Group LLP Boston, MA

40.6M
Shares

$3.05 Billion
0.58% of portfolio
Capital International Investors Los Angeles, CA

36.7M
Shares

$2.76 Billion
0.6% of portfolio
Franklin Resources Inc San Mateo, CA

17.6M
Shares

$1.32 Billion
0.44% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account